Table 2 Number of presentations by persons with OUD to medical settings, 2019 and 2020
From: Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic
2019 | 2020 | p-value | |
|---|---|---|---|
Emergency | |||
Single presentation | 439 (39.1%) | 263 (29.3%) | < 0.001 |
2–3 presentations | 442 (39.4%) | 399 (44.4%) | |
≥ 4 presentations | 242 (21.5%) | 237 (26.4%) | |
Inpatient | |||
Single presentation | 324 (42.1%) | 293 (35.6%) | 0.03 |
2–3 presentations | 254 (33.0%) | 295 (35.8%) | |
≥ 4 presentations | 192 (24.9%) | 236 (28.6%) | |
Outpatient | |||
Single presentation | 261 (24.4%) | 186 (20.3%) | 0.0487 |
2–3 presentations | 363 (34.0%) | 309 (33.7%) | |
≥ 4 presentations | 445 (41.6%) | 423 (46.1%) | |